W. R. Berkley (NYSE:WRB) PT Raised to $95.00 at The Goldman Sachs Group

W. R. Berkley (NYSE:WRB) had its price target raised by analysts at The Goldman Sachs Group from $86.00 to $95.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the insurance provider’s stock. The Goldman Sachs Group’s price objective suggests a potential upside of 15.64% from the stock’s previous close.

WRB has been the subject of several other research reports. StockNews.com lowered W. R. Berkley from a “buy” rating to a “hold” rating in a report on Thursday. Keefe, Bruyette & Woods boosted their price target on W. R. Berkley from $85.00 to $88.00 and gave the company a “market perform” rating in a report on Wednesday. Evercore ISI boosted their price target on W. R. Berkley from $83.00 to $89.00 and gave the company an “in-line” rating in a report on Thursday. BMO Capital Markets boosted their price objective on W. R. Berkley from $71.00 to $81.00 and gave the company a “market perform” rating in a research report on Friday, January 26th. Finally, Wells Fargo & Company boosted their price objective on W. R. Berkley from $92.00 to $99.00 and gave the company an “overweight” rating in a research report on Thursday. Five investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, W. R. Berkley has a consensus rating of “Moderate Buy” and an average price target of $89.22.

W. R. Berkley Stock Down 0.0 %

W. R. Berkley stock opened at $82.15 on Friday. The firm has a market cap of $21.08 billion, a price-to-earnings ratio of 16.24, a PEG ratio of 1.53 and a beta of 0.57. The stock has a fifty day simple moving average of $84.42 and a two-hundred day simple moving average of $75.17. W. R. Berkley has a 12 month low of $55.50 and a 12 month high of $89.18. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.38.

W. R. Berkley (NYSE:WRB) last posted its earnings results on Wednesday, January 24th. The insurance provider reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.35 by $0.10. The business had revenue of $3.22 billion during the quarter, compared to analyst estimates of $2.70 billion. W. R. Berkley had a return on equity of 19.03% and a net margin of 11.38%. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.16 EPS. Equities analysts predict that W. R. Berkley will post 5.98 EPS for the current fiscal year.

Institutional Investors Weigh In On W. R. Berkley

Hedge funds have recently made changes to their positions in the company. Bruce G. Allen Investments LLC purchased a new stake in shares of W. R. Berkley in the fourth quarter worth about $25,000. Glassman Wealth Services lifted its position in shares of W. R. Berkley by 123.1% in the fourth quarter. Glassman Wealth Services now owns 357 shares of the insurance provider’s stock worth $25,000 after buying an additional 197 shares in the last quarter. Clear Street Markets LLC lifted its position in shares of W. R. Berkley by 92.3% in the first quarter. Clear Street Markets LLC now owns 398 shares of the insurance provider’s stock worth $25,000 after buying an additional 191 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in W. R. Berkley by 106.1% during the third quarter. Parkside Financial Bank & Trust now owns 406 shares of the insurance provider’s stock worth $26,000 after acquiring an additional 209 shares during the last quarter. Finally, Raleigh Capital Management Inc. increased its stake in W. R. Berkley by 132.6% during the third quarter. Raleigh Capital Management Inc. now owns 414 shares of the insurance provider’s stock worth $26,000 after acquiring an additional 236 shares during the last quarter. 68.82% of the stock is currently owned by hedge funds and other institutional investors.

W. R. Berkley Company Profile

W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writers worldwide. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines.